Gyre Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GYRE and other ETFs, options, and stocks.About GYRE
Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis).
GYRE Key Statistics
Stock Snapshot
The current Gyre Therapeutics(GYRE) stock price is $7.78, with a market capitalization of 756.55M. The stock trades at a price-to-earnings (P/E) ratio of 345.78.
Gyre Therapeutics(GYRE) stock opened on 2026-05-06 at $8.02. The price climbed to — and dipped to —.
Gyre Therapeutics(GYRE) shares are trading with a volume of 0, against a daily average of 50.4K.
In the last year, Gyre Therapeutics(GYRE) shares hit a 52-week high of $11.78 and a 52-week low of $6.57.
In the last year, Gyre Therapeutics(GYRE) shares hit a 52-week high of $11.78 and a 52-week low of $6.57.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.